Our findings of increased NPC staining in ovarian and mammary tumors substantiate this, and expression profiling confirmed an early observation that mRNA for Nup88 was over-expressed in a panel of ovarian carcinoma cell lines [46]. This evidence concerns the gene NUP88 and breast cancer.